ElectroCore has raised $36 million in a new round of equity and options financing, according to an SEC filing posted this week.
The Basking Ridge, N.J.-based company is seeking an additional $29 million in the round to bring the total to $65 million.
Funds raised so far have come from 31 unnamed investors, with the 1st sale dated on August 21, according to the SEC filing.
Electrocore developed and produces the gammaCore non-invasive vagus nerve stimulator. The device won FDA approval in April and was launched in mid-July with indications for treating pain associated with episodic cluster headaches in adult patients.
In June, MassDevice.com spoke to ElectroCore CEO Amato about the gammaCore device and how the device differs from other VNS therapy systems